depressive disorder, major

Showing 26 - 50 of 302

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Major Depressive Disorder Who Have HadInadequate Response

Terminated
  • Depressive Disorder, Major
  • Standard of Care (SOC)
  • San Francisco, California
  • +3 more
Dec 6, 2022

Depressive Disorder, Major, Treatment Resistant Depression, Melancholia Trial in Ghent (device, behavioral, drug)

Recruiting
  • Depressive Disorder, Major
  • +2 more
  • aiTBS
  • +2 more
  • Ghent, East-Flanders, Belgium
    University Hospital Ghent
Dec 6, 2022

Electroconvulsive Therapy

Not yet recruiting
  • Depressive Disorder, Major
  • Electroconvulsive therapy
  • (no location specified)
Nov 18, 2022

Depressive Disorder, Major, Treatment Outcome, Cognitive Dysfunction Trial in Copenhagen (Treatment Package for First-Episode

Recruiting
  • Depressive Disorder, Major
  • +4 more
  • Treatment Package for First-Episode Depression
  • Copenhagen, Denmark
    Neurobiology Research Unit, Rigshospitalet
Nov 12, 2022

Depressive Disorder, Major, Anxiety Disorder Trial (Nociceptin Receptor Antagonist, Aversive stimuli)

Not yet recruiting
  • Depressive Disorder, Major
  • Anxiety Disorder
  • Nociceptin Receptor Antagonist
  • Aversive stimuli
  • (no location specified)
Nov 3, 2022

Depressive Disorder, Major Trial in Worldwide (Seltorexant, Placebo)

Terminated
  • Depressive Disorder, Major
  • Phoenix, Arizona
  • +79 more
Oct 3, 2022

Depressive Disorder, Major, Inflammation Trial in Amsterdam (Celecoxib 400mg, Placebo)

Recruiting
  • Depressive Disorder, Major
  • Inflammation
  • Celecoxib 400mg
  • Placebo
  • Amsterdam, Netherlands
    Department of Psychiatry Amsterdam UMC
Sep 28, 2022

Depressive Disorder, Major Trial in United States (Esketamine, Aripiprazole)

Not yet recruiting
  • Depressive Disorder, Major
  • Tuscaloosa, Alabama
  • +26 more
Sep 21, 2022

Spinal Cord Injuries, Depression, Depressive Disorder, Major Trial in Charleston (repetitive transcranial magnetic stimulation)

Not yet recruiting
  • Spinal Cord Injuries
  • +2 more
  • repetitive transcranial magnetic stimulation
  • Charleston, South Carolina
    Ralph H. Johnson VA Medical Center, Charleston, SC
Sep 20, 2022

Depressive Disorder, Major Trial in Worldwide (Vortioxetine 10 mg/day, Vortioxetine 20 mg/day, Fluoxetine 20mg/day)

Completed
  • Depressive Disorder, Major
  • Vortioxetine 10 mg/day
  • +3 more
  • Little Rock, Arkansas
  • +97 more
Aug 29, 2022

General Psychopathology, Fatigue, Depressive Disorder, Major Trial in Münsterlingen (Integrated 5-day Gratitude Exercise and

Recruiting
  • General Psychopathology
  • +2 more
  • Integrated 5-day Gratitude Exercise and Behavioral Activation Program
  • Münsterlingen, Thurgau, Switzerland
    Psychiatric Service Thurgau
Sep 15, 2022

Depressive Disorder, Major Trial in Worldwide (Esketamine 28 mg, Esketamine 56 mg, Esketamine 84 mg)

Completed
  • Depressive Disorder, Major
  • Esketamine 28 mg
  • +6 more
  • Ciudad Autonoma de Buenos Aires, Argentina
  • +170 more
Sep 13, 2022

Depression, Depressive Disorder, Depressive Disorder, Major Trial in France (microbiotherapy (GynMDD), )

Recruiting
  • Depression
  • +2 more
  • microbiotherapy (GynMDD)
  • placebo
  • Besançon, France
  • +3 more
Sep 8, 2022

Depressive Disorder, Major Trial in Worldwide (BI 1358894, Placebo, Quetiapine)

Recruiting
  • Depressive Disorder, Major
  • BI 1358894
  • +2 more
  • Birmingham, Alabama
  • +83 more
Aug 22, 2022

Depressive Disorder, Major Trial in Alken, Aachen (Seltorexant Dose 1, Seltorexant Dose 2, Placebo)

Recruiting
  • Depressive Disorder, Major
  • Seltorexant Dose 1
  • +3 more
  • Alken, Belgium
  • +1 more
Aug 17, 2022

Depressive Disorder, Major Trial in Worldwide (Intranasal Placebo, Midazolam Placebo Solution, Midazolam)

Recruiting
  • Depressive Disorder, Major
  • Intranasal Placebo
  • +3 more
  • Panorama City, California
  • +65 more
Aug 17, 2022

Depressive Disorder, Major Trial in Worldwide (Seltorexant, Placebo)

Recruiting
  • Depressive Disorder, Major
  • San Diego, California
  • +26 more
Aug 17, 2022

Digital Care Chains in Health Care -Study of Care Consumption,

Active, not recruiting
  • Depression
  • +4 more
  • Digital healthcare platform
  • Gävle, Gävleborg, Sweden
    County of Gavleborg
Aug 16, 2022

Depressive Disorder, Major, Bipolar Disorder, Post Traumatic Stress Disorder Trial in New Haven (Ketamine, Perampanel, Placebo)

Recruiting
  • Depressive Disorder, Major
  • +2 more
  • New Haven, Connecticut
    Yale University
Aug 8, 2022

Pharmacogenetics, Depressive Disorder, Major, Medication Therapy Management Trial in Tuscaloosa (Pharmacogenomic Screening)

Withdrawn
  • Pharmacogenetics
  • +2 more
  • Pharmacogenomic Screening
  • Tuscaloosa, Alabama
    Tuscaloosa VAMC
Aug 8, 2022

Schizophrenia, Bipolar Disorder, Depressive Disorder, Major Trial in Minneapolis (Social Cognition and Interaction Training-Work

Not yet recruiting
  • Schizophrenia
  • +3 more
  • Social Cognition and Interaction Training-Work Edition (SCIT-WE)
  • Minneapolis, Minnesota
    Minneapolis VA Health Care System, Minneapolis, MN
Aug 4, 2022

Stress Disorders, Post-Traumatic, Depressive Disorder, Major, Anxiety Disorder Trial in Marseille, Montpellier, Tours (Clinical,

Not yet recruiting
  • Stress Disorders, Post-Traumatic
  • +2 more
  • Clinical, cognitive and biological tests
  • Marseille, France
  • +3 more
Aug 4, 2022

Depressive Disorder, Major Trial in United States (AGN-241751, Placebo)

Completed
  • Depressive Disorder, Major
  • Fayetteville, Arkansas
  • +24 more
Aug 1, 2022

Depressive Disorder, Major, Suicidal Trial in United States (drug, other, device)

Recruiting
  • Depressive Disorder, Major
  • Suicidal
  • Tempe, Arizona
  • +29 more
Jul 25, 2022